semaglutide launch title Today we launch, Obeda®, India's first DCGI-approved generic injection for Type 2 Diabetes. This product reinforces our purpose of good health cant wait, to bring high quality and affordable treatment FDA vs. HIMS: Why the

GLP-1 medicines have become widely prescribed, yet their mechanism of action in the body, beyond appetite suppression and blood sugar control, have remained incompletely understood

They bind to specific receptors and trigger a targeted biological response, and many of the therapeutic ones are bioidentical or near-bioidentical to compounds your body already produces

By correcting conditions like megaloblastic anemia, these injections ensure your body has plenty of healthy red blood cells to carry oxygen where it needs to go

Glp1r Tie2/ mice were generated by crossing Glp1r fl/fl mice with Tg (Tek-Cre)1Ywa ( Tie2) Cre mice (Jackson Laboratory, 008863) to target endothelial and immune cells in the Tie2 domain, as previously described (25, 26)